Cargando…
Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic
Accumulating evidence suggests that influenza and influenza-like illnesses can act as a trigger for acute myocardial infarction. Despite these unprecedented times providers should not overlook acute coronary syndrome (ACS) guidelines, but may choose to modify the recommended approach in situations w...
Autores principales: | Briedis, Kasparas, Aldujeli, Ali, Aldujeili, Montazar, Briede, Kamilija, Zaliunas, Remigijus, Hamadeh, Anas, Stoler, Robert C., McCullough, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324338/ https://www.ncbi.nlm.nih.gov/pubmed/32723554 http://dx.doi.org/10.1016/j.amjcard.2020.06.039 |
Ejemplares similares
-
Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic
por: Aldujeli, Ali, et al.
Publicado: (2020) -
Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic
por: Aldujeli, Ali, et al.
Publicado: (2021) -
TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy
por: Hamadeh, Anas, et al.
Publicado: (2020) -
Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction
por: Hamadeh, Anas, et al.
Publicado: (2020) -
Safety and performance of the Vienna self-expandable transcatheter aortic valve system: 6-month results of the VIVA first-in-human feasibility study
por: Briedis, Kasparas, et al.
Publicado: (2023)